Zyvox (Linezolid) Special Investigation For Vancomycin-Resistant Enterococci (VRE)

Pfizer

Status: Completed

Conditions: Vancomycin Resistance Enterococcus Faecium

Treatments: Drug: Zyvox (linezolid)

Study type: Observational

Funder types: Industry

Identifiers

NCT01224626

A5951139

Details and patient eligibility

About

To collect the efficacy and safety information in subjects who have been treated with Zyvox (linezolid) for vancomycin resistance Enterococcus faecium infection for their appropriate use in daily practice.

Enrollment: 41 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Subject to whom Zyvox (linezolid) was administered.
• Infected subject with Vancomycin resistance Enterococcus faecium.

Exclusion criteria

• Infected subject with MRSA and other organism.

Trial design

41 participants in 1 patient group

Zyvox (linezolid)

Description:

Patients who have been treated with Zyvox (linezolid).

Treatment:

Drug: Zyvox (linezolid)